Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

mrvl:cc

POPULAR ARTICLES

Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204

Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204

Marvel Biosciences Announces Grant of Deferred Share Units

Marvel Biosciences Announces Grant of Deferred Share Units

Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit

Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit

LATEST ARTICLES

Marvel Biosciences Announces Closing of Convertible Debenture Offering

Marvel Biosciences Announces Closing of Convertible Debenture Offering

Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders

Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders

Marvel Biosciences Announces an Amendment to the Conversion Price for Marvel's Proposed Convertible Debenture Offering

Marvel Biosciences Announces an Amendment to the Conversion Price for Marvel's Proposed Convertible Debenture Offering

Marvel Biosciences Announces Proposed Convertible Debenture Offering

Marvel Biosciences Announces Proposed Convertible Debenture Offering

Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures

Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures

Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204

Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204

Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Marvel Biosciences Sponsors Scientific Meeting on Purines

Marvel Biosciences Sponsors Scientific Meeting on Purines

Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204

Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite

Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite

Latest News

Further High-Grade Copper Intercepts at Chester

Trading Halt

Valeura Energy Inc. Announces Completion of Nong Yao Drilling Campaign

Successful Placement Accelerates Operations

Brixton Metals Launches Drilling Campaign at Langis Project

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Gemdale Gold

Gemdale Gold (GEMG:CC)

GEMG:CC

Premier American Uranium

Premier American Uranium (PUR:CC)

PUR:CC

VanadiumCorp Resource

VanadiumCorp Resource (VRB:CC)

VRB:CC

GoldInxs Mining

GoldInxs Mining (INXS:CC)

INXS:CC

Finlay Minerals

Finlay Minerals (FYL:CC)

FYL:CC

Coelacanth Energy

Coelacanth Energy (CEI:CC)

CEI:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES